According to latest Symphony Health Solutions Rx data Zubsolv tablets market share (4-week rolling average) reached 6.12% (6.16%). The total number of Zubsolv tablets sold week 37 (36) increased to 340,745 (318,278). Zubsolv prescriptions (TRx) recorded a market share (4-week rolling average) of 6.19% (6.21%), totaling 12,436 (11,575) prescriptions during the week. The overall market (buprenorphine/naloxone products) showed a y/y growth rate of 6.6% (6.7%) (4-week rolling average unit sales). TRx showed a y/y growth rate by 5.8% (6.1%) (4-week rolling average).